Clinical Trials Directory

Trials / Completed

CompletedNCT00527501

IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular Hypertension

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
136 (actual)
Sponsor
Alcon Research · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the safety and IOP-lowering efficacy of a fixed combination of Travoprost/Brinzolamide Ophthalmuc Suspension dosed BID and QD, to TRAVATAN dosed QD and a Vehicle dosed BID in patients with open-angle glaucoma or ocular hypertension.

Conditions

Interventions

TypeNameDescription
DRUGTravoprost/brinzolamide

Timeline

Start date
2007-08-01
Primary completion
2007-12-01
Completion
2007-12-01
First posted
2007-09-11
Last updated
2012-04-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00527501. Inclusion in this directory is not an endorsement.